drug: naltrexone

• Clinical class: anti-alcoholic, opioid dependence treatment adjunct
• Action: opioid antagonist
• Active metabolite: 6β naltrexol
• CSA schedule: none
• DEA number: none
• MEDLINEplus^® Drug Information

U.S. Preparations:

• Depade^® (Mallinckrodt) FDA approved:
  3.2.2002 for treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids
  12.2006 ceased production
  Prescribing Information

• Naltrel™ (DrugAbuse Sciences) in development
• ReVia^® (DuPont Pharma) FDA approved for treatment of: narcotic and alcohol dependence
• Trexan^® (archaic)
• Trexonil^® (veterinary, Wildlife Pharmaceuticals) FDA approved for treatment of : not approved for human use
• Vivitrol™ (previously Vivitrex^®) (Alkermes, Cephalon) FDA approved:
  4.13.2006 for treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with Vivitrol™
  Prescribing Information
• generic

Foreign Preparations:

• Antaxone, Celupan, Nalorex, Narcoral, Nemexin

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®